ClinicalTrials.gg
RecruitingNCT07290556Updated Jun 24, 2026

Establishing the Preliminary Utility of a Novel Pediatric Manual Mobile Standing Wheelchair

An interventional study of PedMMSWC Wheelchair User Testing and PedMMSWC Simulated Home, School, Community Environment in Spina Bifida, sponsored by Optimal Mobility, Inc. Recruiting at 1 site in United States. Open to participants aged 8 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-06-24.

Sponsored by Optimal Mobility, Inc · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Jun 2026; still recruiting 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Non-randomized
Ages
8 Years to 17 Years
Sex
All
01

Study summary

To establish the preliminary utility of a novel pediatric manual mobile standing wheelchair (PedMMSWC).

02

Conditions studied

  • Spina Bifida

Browse trials for

Keywords

  • Spinal Bifida
  • Wheelchair
  • Pediatric
  • Standing
03

In context

Spinal Dysraphism

142 studies on the registry are indexed under Spinal Dysraphism; 39 are open to participants now.

This study's planned enrollment of 30 is close to the median of 30 across 91 interventional studies indexed under Spinal Dysraphism.

Browse Spinal Dysraphism studies →

Lead sponsor

This is the only study on the registry with Optimal Mobility, Inc as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 8 - 17 years old
  • Primarily use a manual wheelchair for daily mobility
  • Are actively enrolled in a standing program
  • Fit the height and weight requirements of the PedMMSWC
  • Can follow simple verbal instructions
  • Are able to speak and read in English

Exclusion criteria

Exclusion Criteria:

  • Have insufficient trunk control to maneuver in seated and standing positions
  • Have lower limb contracture which would preclude standing
  • Have had orthopedic surgery within the last twelve months
  • Have pressure injuries at the location where the PedMMSWC interfaces
  • Have insufficient fine motor skills to independently initiate the sit-to-stand function
  • Have a history of uncontrolled seizures or cardiovascular conditions that would make participation unsafe
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Experiment 1: In-Lab Testing

    Perform tasks in a laboratory environment designed to test the maneuverability and ease of use of the PedMMSWC as compared to commercial devices.

    Device: PedMMSWC Wheelchair User Testing

  • Experimental
    Experiment 2: Simulated Community and Home Testing

    Perform tasks in a simulated home, school, and community setting using the PedMedWC wheelchair.

    Device: PedMMSWC Simulated Home, School, Community Environment

Interventions

  • DevicePedMMSWC Wheelchair User Testing

    The PedMMSWC standing wheelchair prototype will be tested and compared with a standing frame during Experiment 1: In-Lab Testing.

  • DevicePedMMSWC Simulated Home, School, Community Environment

    The PedMMSWC standing wheelchair will be tested in a simulated home, school, and community environment. Participants will be given assigned tasks and be scored on completion of activities.

06

What researchers measure

Primary outcomes

  1. Comparison of a modified Wheelchair Skills Test with Participants wheelchair to the PedMMSWC

    The primary outcome measure for this aim is user performance on a modified Wheelchair Skills Test (mWST) under three test conditions: PedMMSWC in the seated position, PedMMSWC in the standing position, and the individuals' daily wheelchair. The investigators hypothesize that performance on the mWST in the PedMMSWC will not be clinically inferior to performance in individuals' daily wheelchairs.

    Time frame: Day 1

Secondary outcomes

  1. 100-Meter Roll Test (meters per second)

    Participants will perform a 100-meter roll test in the PedMMSWC (in seated and standing) and their daily wheelchair (dWC). This test is originally described in the WST Version 4.1 and measures how quickly (meters per second) participants can cover 100 meters in their wheelchair over hard, flat, level ground. Participants will perform the test once in each device condition (PedMMSWC-Seated, PedMMSWC-Standing, dWC), rate their perceived exertion, and speed following each test.

    Time frame: Day 1

  2. 100-Meter Roll Test (perceived exertion)

    Participants will perform a 100-meter roll test in the PedMMSWC (in seated and standing) and their daily wheelchair (dWC). This test measures how much effort (percieved exertion) participants use to cover 100 meters in their wheelchair over hard, flat, level ground. Participants will perform the test once in each device condition (PedMMSWC-Seated, PedMMSWC-Standing, dWC) and rate their perceived exertion.

    Time frame: Day 1

  3. Pressure Mapping (peak pressure (mm/hg))

    Participants will be measured with a pressure mapping device for peak pressure (mm/hg) in the PedMMSWC sitting, PedMMSWC standing, and the Easy Stand Device on interfacing surfaces.

    Time frame: Day 1

  4. Pressure Mapping (coefficient of variation)

    Participants will be measured with a pressure mapping device for coefficient of variation in the PedMMSWC sitting, PedMMSWC standing, and the Easy Stand Device on interfacing surfaces.

    Time frame: Day 1

  5. Functional Mobility Assessment - Family Centered (FMA-FC)

    To capture baseline satisfaction with individuals' primary wheelchair, each participant and their caregiver will collaboratively complete the FMA-FC outcome measure, which has been specifically designed and validated for pediatric use.

    Time frame: Day 1 or 2

  6. Participant and Caregiver Perceptions of Device

    Participants will complete a course in the PedMMSWC and their dWC designed to simulate typical activities in home, school, and community environments. In each of these environments, participants will engage in a series of structured activities tailored to their developmental level. While using the PedMMSWC, participants will also complete a 'free play' period during which they will be encouraged to explore and spontaneously interact with the space. Individuals will have free choice to move between seated and standing positions in the PedMMSWC for all tasks and play. Outcomes: qualitative and coded interview data, why and how often sit-to-stand transitions occur, the time spent standing, and therapist score task completion and safety on a 4-point scale.

    Time frame: Day 1 or Day 2

  7. System Usability Scale

    The SUS is a validated, 10-item quantitative scale used to measure the usability of an interactive system. Participants and their caregivers will complete the SUS in collaboration.

    Time frame: Visit 1

Other outcomes

  1. User-Device Movement during Sit-to-Stand Transitions (degrees of motion)

    Using body motion analysis, investigators will record and analyze sit-to-stand transitions in a standing frame and the PedMMSWC wheelchair. Measuring three dimensional rotation of the thigh, shank, torso segments relative to the wheelchair during sit to stand transitions. during sit-to-stand transitions.

    Time frame: Day 1

  2. User-Device Movement during Sit-to-Stand Transitions (mm)

    Using body motion analysis, investigators will record and analyze sit-to-stand transitions in a standing frame and the PedMMSWC wheelchair. Measuring the offset and translation (mm) of the body segments (trunk and thigh) relative to the chair or standing frame during sit-to-stand transitions.

    Time frame: Day 1

  3. User-Device Movement during Sit-to-Stand Transitions (seconds)

    Using body motion analysis, investigators will record and analyze sit-to-stand transitions in a standing frame and the PedMMSWC wheelchair. Measuring time-to-stand (seconds), time-to-sit (seconds) in the chair or standing frame during sit-to-stand transitions.

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
  • Gillette Children's Specialty Healthcare
    Saint Paul, Minnesota 55101, United States
    Recruiting
    • Mark Jankowski · ContactMarkDJankowski@gillettechildrens.com · 651-229-1760
    • Alyssa M Spomer, PhD · Principal investigator
    • Linda Krach, MD · Sub investigator
    • Sara J Morgan, PhD · Sub investigator
    • Mark Jankowski · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Aug 2027, 14 months after the start.

Of 62 interventional studies with no phase under Spinal Dysraphism, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 20 and three quarters within 57. This study's planned 14 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 25, 2025
First posted
Dec 18, 2025
StartActual
Jun 18, 2026
Primary completionEst.
Aug 25, 2027
CompletionEst.
Aug 25, 2027
Last update
Jun 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07290556
Lead sponsor
Optimal Mobility, Inc
Collaborators
Gillette Children's Specialty Healthcare, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Minneapolis Veterans Affairs Medical Center
Responsible party
Sponsor
First posted
Dec 18, 2025
Start date
Jun 18, 2026
Primary completion
Aug 25, 2027 (estimated)
Completion
Aug 25, 2027 (estimated)
Last update
Jun 24, 2026

Study contacts

Patricia McCraken, DPT, MBA
Contact
pmccraken@optimal-mobility.com
320-247-2104

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion